Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal

Experts spoke with HBW Insight about potential impact on US contraceptive market from Supreme Court’s decision in Dobbs v. Jackson overturning its 1973 ruling in Roe v. Wade, which was upheld in 1992 ruling in Planned Parenthood v. Casey, stating a woman has a constitutional right to reproductive health services.

More than 60 years after daily oral contraceptives were made available Rx in the US, extending sales for the first time to OTC is proposed against a backdrop of political and judicial pressures potentially imposing restrictions on access to all birth control drugs.

“I think that in the wake of Dobbs, there's certainly a sense of panic across truly many different sectors in...